GlassScriptPhysician profile
Vladimir Zeetser
NPI 1366449985
$676,911.76
in general payments reported to CMS, 2019-2025
32 companies · $172K in 2025
The $172K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,019 · 2020: $5,363 · 2021: $43K · 2022: $151K · 2023: $151K · 2024: $151K · 2025: $172K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $470K · Food and Beverage: $3,679 · Debt Forgiveness: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $470,000.00 |
| Food and Beverage | $3,679.09 |
| Debt Forgiveness | $992.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $662,869.75 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Smith+Nephew, INC. | $4,439.91 | 2019-2025 | Stravix, Grafix Pl, Oasis |
| Cardiovascular Systems INC. | $3,038.41 | 2019-2023 | Diamondback Peripheral |
| Philips North America LLC | $926.93 | 2019-2021 | |
| Olympus America INC. | $820.16 | 2025 | |
| Abbott Laboratories | $777.97 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $625.05 | 2019-2021 | |
| Amgen INC. | $607.88 | 2024-2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $354.43 | 2022-2025 | Nuzyra |
| Asahi Intecc USA, INC. | $280.77 | 2021-2023 | Asahi Ptca Guide Wire |
| Organogenesis INC. | $237.50 | 2023 | Puraply |
| Horizon Therapeutics Plc | $213.54 | 2021-2023 | Krystexxa |
| Cardinal Health 200 LLC | $204.70 | 2019-2020 | |
| Abbvie INC. | $198.87 | 2023-2024 | Dalvance |
| Veryan Medical Incorporated | $173.23 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $172.92 | 2019 | |
| Djo, LLC | $172.00 | 2024 | |
| Integra Lifesciences Corporation | $163.86 | 2019-2021 | |
| Medline Industries LP | $155.06 | 2023-2025 | |
| Advanced Oxygen Therapy INC. | $143.63 | 2024 | Topical Oxygen Chamber For Extremities |
| Medtronic, INC. | $68.53 | 2025 | Venaseal |
| Cordis US Corp. | $54.63 | 2023 | Mynx Control |
| Grt US Holding, INC. | $32.84 | 2021 | |
| Lilly USA, LLC | $24.45 | 2023 | Taltz |
| Terumo Medical Corporation | $24.40 | 2020 | |
| Cook Medical LLC | $23.93 | 2019 | |
| Anika Therapeutics, INC. | $22.41 | 2021 | |
| Ascensia Diabetes Care US INC. | $21.41 | 2021 | |
| Curonix LLC | $18.17 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Sandoz INC. | $17.55 | 2019 | |
| Wright Medical Technology, INC. | $15.01 | 2019 | |
| Paragon 28, INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vladimir Zeetser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.